Atomic emission method for total boron in blood during neutron-capture therapy

Clinical Chemistry

Volumn 47, Issue 10, 2001, Pages 1796-1803

  Laakso, J ^a   Kulvik, M ^a   Ruokonen, I ^a   Vahatalo J ^a   Zilliacus, R ^a   Farkkila M ^a   Kallio, M ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

4 DIHYDROXYBORYLPHENYLALANINE; BORON; CALCIUM; TRICHLOROACETIC ACID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CALCIUM BLOOD LEVEL; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DRUG TARGETING; FEMALE; HEMATOCRIT; HUMAN; MALE; NEUTRON CAPTURE THERAPY; NEUTRON RADIATION; RADIATION DOSE;

EID: 0034834306     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.10.1796     Document Type: Article

References (23)

1. Boron neutron capture therapy of brain tumors: An emerging therapeutic modality
2. Boron neutron capture therapy for malignant gliomas
3. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory
4. Improved boron determination in biological material by inductively coupled plasma mass spectrometry
5. Boron analysis in biological material: Microwave digestion procedure and determination by different methods
6. Methods for boron analysis in boron neutron capture therapy (BNCT)
7. Determination of boron in tissues and cells using direct-current plasma atomic emission spectroscopy
8. Determination of the concentration of complex boronated compounds in biological tissues by inductively coupled plasma atomic emission spectrometry
9. Microanalysis system of ppm-order 10B concentrations in tissue for neutron capture therapy by prompt γ-ray spectrometry
10. Monitoring of blood-10B concentration for boron neutron capture therapy using prompt γ-ray analysis
11. Biodistribution of boronophenylatanine in patients with glioblastoma multiforma: Boron concentration correlates with tumor cellularity
12. Determination of boron in food and biological materials by neutron capture prompt-γ activation
13. Statistical methods for assessing agreement between two methods of clinical measurement
14. Effect of dose and infusion time on the delivery of p-boronophenylalanine for neutron capture therapy
15. Determination of boron in human serum by inductively coupled plasma mass spectrometry after a simple dilution of the sample
16. A comparative review of the pharmacokinetics of boric acid in rodents and humans
17. Boron neutron capture therapy for glioblastoma multiforme: Interim results from the phase I/II dose-escalation studies
18. Determination of glycated albumin by enzyme-linked boronate immunoassay (ELBIA)
19. Determination of boronophenytalanine in biological samples using precolumn o-pthalaidehyde derivatization and reversed-phase high-performance liquid chromatography
20. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: Part I and II
21. Red cell phenylalanine is not available for transport through the blood-brain barrier
22. The distribution of amino acids between plasma and erythrocytes
23. The combined effect of boronophenylalanine and borocaptate in boron neutron capture therapy for SCCVII tumors in mice